Skip to main content
Explore URMC

URMC Logo

menu

News

20192018201720162015 Archive

Multi-Target Drugs Should Be in the Pharma Pipeline along with Precision Drugs

Thursday, January 31, 2019

“Precision medicine—providing the right treatment, for the right patient, at the right time—is saving lives. The use of therapies that home in on single targets is helping beat tough-to-treat diseases that were often deadly in the past,” writes Harris Gelbard, a professor of neurology, pediatrics, neuroscience, and microbiology and immunology, who is also director of the Medical Center’s Center for Neurotherapeutics Discovery. “But we’re overlooking another class of extremely important and promising candidates: multi-target drugs.”

Read More: Multi-Target Drugs Should Be in the Pharma Pipeline along with Precision Drugs